ACI Formulations PLC announcements
278 Dhaka Stock Exchange announcements for ACI Formulations PLC (ACIFORMULA) since 2008: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2025 (16).
- Resumption after Record Date
Trading of the shares of the company will resume on 20.11.2025.
- Suspension for Record Date
Trading of the shares of the company will remain suspended on record date i.e., 19.11.2025.
- Spot News
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 17.11.2025 to 18.11.2025 and trading of the shares will remain suspended on record date i.e., 19.11.2025.
- Q1 Financials
(Q1 Un-audited): Consolidated EPS was Tk. 1.85 for July-September 2025 as against Tk. 2.35 for July-September 2024. Consolidated NOCFPS was Tk. (6.48) for July-September 2025 as against Tk. (3.86) for July-September 2024. Consolidated NAV per share was Tk. 77.36 as on September 30, 2025 and Tk. 75.51 as on June 30, 2025. Reasons for deviation: Consolidated revenue increased by 10% over SPLY. (cont.1) (cont. news of ACIFORMULA): Overall effect resulted consolidated profit after tax of Tk. 87.70 Mn against Tk. 111.29 Mn of SPLY resulting in lower consolidated EPS. On the other hand, consolidated NOCFPS decreased due to ensure adequate inventory in the upcoming season over SPLY. (end) (cont. news of ACIFORMULA): Despite that GP increased by 0.16% due to increase of raw material and packing material price in the international market. On other hand, overall operating expenses increased by 20% due to inflationary effects and higher cost of exports. On the other hand, financing cost reduced by 22% due to fluctuation gain resulted from trade financing. (cont.2)
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 12, 2025 at 2:45 PM to consider, among others, Un-audited financial statements of the Company for the First Quarter (Q1) period ended September 30, 2025.
- Dividend Declaration (Additional Information)
Refer to the earlier news disseminated by DSE on 29.10.2025 regarding dividend declaration, the company has further informed that the recommended for 25% Cash is from it retained earnings for the year ended June 30, 2025. The declared dividend has not been recommended from capital reserve or revaluation reserve or any unrealized gain of the company or through reducing the paid-up capital.
- Dividend Declaration
The Board of Directors has recommended 25% Cash Dividend for the year ended June 30, 2025. Date of AGM: 28.12.2025, Time: 10:00 AM, Venue: Digital System. Record Date: 19.11.2025. The Company has also reported Consolidated EPS of Tk. 7.85, Consolidated NAV per share of Tk. 75.51 and Consolidated NOCFPS of Tk. 0.66 for the year ended June 30, 2025 as against Consolidated EPS of Tk. 6.88, Consolidated NAV per share of Tk. 68.94 and Consolidated NOCFPS of Tk. 14.78 for the year ended June 30, 2024.
- Price Limit Open
There will be no price limit on the trading of the shares of the Company today (29.10.2025) following its corporate declaration.
- Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 28, 2025 at 2:45 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2025.
- Name Change of the Company
Dhaka Stock Exchange PLC. (DSE) has approved the proposed name change of the Company. Accordingly, the name of the Company will be 'ACI Formulations PLC' instead of 'ACI Formulations Limited' with effect from July 08, 2025. Other information (except name) will remain unchanged.
- Q3 Financials
(Q3 Un-audited): Consolidated EPS was Tk. 1.89 for January-March 2025 as against Tk. 2.04 for January-March 2024; Consolidated EPS was Tk. 8.65 for July 2024-March 2025 as against Tk. 6.38 for July 2023-March 2024. Consolidated NOCFPS was Tk. 3.53 for July 2024-March 2025 as against Tk. 8.65 for July 2023-March 2024. Consolidated NAV per share was Tk. 75.59 as on March 31, 2025 and Tk. 68.94 as on June 30, 2024.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 29, 2025 at 2:45 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended March 31, 2025.
- Dividend Disbursement
The Company has informed that it has disbursed the Cash Dividend for the year ended June 30, 2024 to the respective shareholders.
- Q2 Financials
(Q2 Un-audited): Consolidated EPS was Tk. 4.40 for October-December 2024 as against Tk. 2.70 for October-December 2023; Consolidated EPS was Tk. 6.75 for July-December 2024 as against Tk. 4.34 for July-December 2023. Consolidated NOCFPS was Tk. 2.95 for July-December 2024 as against Tk. 6.89 for July-December 2023. Consolidated NAV per share was Tk. 73.70 as on December 31, 2024 and Tk. 68.94 as on June 30, 2024.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 30, 2025 at 2:45 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended December 31, 2024.
- Credit Rating Result
Credit Rating Information and Services Limited (CRISL) has assigned the rating of the Company as "AA-" in the long term and "ST-3" in the short term along with Stable outlook in consideration of its audited financials up to June 30, 2024 also unaudited financials up to September 30, 2024 and other relevant quantitative as well as qualitative information up to the date of rating declaration.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.